The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review
Abstract
Experts on psoriasis convened with authorities from other medical specialties to discuss the recently described association between psoriasis, obesity and subsequent cardiovascular comorbidity. Similar to other diseases of increased systemic inflammation, psoriasis has been linked to a heightened risk of myocardial infarction, especially in the more severely affected, younger patients. However, unlike in other inflammatory diseases - such as rheumatoid arthritis - more severely affected patients with psoriasis are much more likely to be obese. Importantly, the pathophysiology of both psoriasis and obesity shows many shared cytokines that are known to contribute to features of the metabolic syndrome, such as hypertension, dyslipidaemia and insulin resistance. The strong association between psoriasis and obesity potentially makes psoriasis an important healthcare issue that requires an update in its standard of care. This meeting reviewed the evidence-based literature and addressed how, moving forward, dermatologists and other specialists may redefine the magnitude of health risk associated with more severe psoriasis and its comorbidities, while clarifying both the epidemiology and pathophysiology of the association with obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
Hill, J. M., Zalos, G., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., & Finkel, T. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022287 · Cited by 3,423
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Circulating endothelial progenitor cells and cardiovascular outcomes
Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., Böhm, M., & Nickenig, G. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043814 · Cited by 2,048
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
Mease, P. J., Goffe, B. S., Metz, J., VanderStoep, A., Finck, B., & Burge, D. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02530-7 · Cited by 1,446
Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis
Solomon, D. H., Karlson, E. W., Rimm, E. B., Cannuscio, C. C., Mandl, L. A., Manson, J. E., Stampfer, M. J., & Curhan, G. C. (2003) · Circulation · doi:10.1161/01.cir.0000054612.26458.b2 · Cited by 1,246
Minireview: The Adipocyte—At the Crossroads of Energy Homeostasis, Inflammation, and Atherosclerosis
Rajala, M. W., & Scherer, P. E. (2003) · Endocrinology · doi:10.1210/en.2003-0580 · Cited by 1,190
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. A., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,127
Prevalence of cardiovascular risk factors in patients with psoriasis
Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., Troxel, A. B., & Gelfand, J. M. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.040 · Cited by 1,010
Pro-inflammatory cytokines and adipose tissue
Coppack, S. W. (2001) · Proceedings of the Nutrition Society · doi:10.1079/pns2001110 · Cited by 1,006
Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis
Sattar, N., McCarey, D. W., Capell, H., & McInnes, I. B. (2003) · Circulation · doi:10.1161/01.cir.0000099844.31524.05 · Cited by 942
The endocrine function of adipose tissue: an update
Ronti, T., Lupattelli, G., & Mannarino, E. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02474.x · Cited by 902
The epidemiology of nonalcoholic fatty liver disease in adults.
Clark, J. M. (2006) · PubMed · doi:10.1097/01.mcg.0000168638.84840.ff · Cited by 762
Disease concomitance in psoriasis
Henseler, T., & Christophers, E. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)91336-x · Cited by 678
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis
Sommer, D. M., Jenisch, S., Suchan, M., Christophers, E., & Weichenthal, M. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0703-z · Cited by 667
Naldi, L., Chatenoud, L., Linder, D., Belloni Fortina, A., Peserico, A., Virgili, A. R., Bruni, P. L., Ingordo, V., Scocco, G. L., Solaroli, C., et al. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23681.x · Cited by 642
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 629
Methotrexate for Rheumatoid Arthritis
Kremer, J. M., Alarcón, G. S., Lightfoot, R. W., Willkens, R. F., Furst, D. E., Williams, H. J., Dent, P. B., & Weinblatt, M. E. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370304 · Cited by 607
The immunologic basis for the treatment of psoriasis with new biologic agents
Krueger, J. G. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120568 · Cited by 600
Hürlimann, D., Forster, A., Noll, G., Enseleit, F., Chenevard, R., Distler, O., Béchir, M., Spieker, L. E., Neidhart, M., Michel, B. A., et al. (2002) · Circulation · doi:10.1161/01.cir.0000037521.71373.44 · Cited by 574
Jacobsson, L., Turesson, C., Gülfe, A., Kapetanovic, M. C., Petersson, I. F., Saxne, T., & Geborek, P. (2005) · PubMed · Cited by 533
Impact of Obesity and Smoking on Psoriasis Presentation and Management
Herron, M. D., Hinckley, M., Hoffman, M. S., Papenfuss, J., Hansen, C. B., Callis, K. P., & Krueger, G. G. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.12.1527 · Cited by 504
Pathology of Nonalcoholic Fatty Liver Disease
Yeh, M. M., & Brunt, E. M. (2007) · American Journal of Clinical Pathology · doi:10.1309/rtpm1py6ygbl2g2r · Cited by 469
Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.
Nickoloff, B. J., Karabin, G. D., Barker, J. N., Griffiths, C. E. M., Sarma, V. J., Mitra, R. S., Elder, J. T., Kunkel, S. L., & Dixit, V. M. (1991) · PubMed Central · Cited by 430
Wållberg‐Jonsson, S., Ohman, M. L., & Dahlqvist, S. R. (1997) · PubMed · Cited by 417
Methotrexate in psoriasis: Consensus conference
Roenigk, H. H., Auerbach, R., Maibach, H., Weinstein, G., & Lebwohl, M. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70508-0 · Cited by 393
Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients
Mallbris, L., Akre, O., Granath, F., Yin, L., Lindelöf, B., Ekbom, A., & Ståhle-Bäckdahl, M. (2004) · European Journal of Epidemiology · doi:10.1023/b:ejep.0000020447.59150.f9 · Cited by 390
PRODANOWICH, S., MA, F., TAYLOR, J., PEZON, C., FASIHI, T., & KIRSNER, R. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.06.017 · Cited by 384
Psoriasis: a possible risk factor for development of coronary artery calcification
Ludwig, R. J., Herzog, C., Rostock, A., Ochsendorf, F. R., Zollner, T. M., Thaci, D., Kaufmann, R., Vogl, T. J., & Boehncke, W.-H. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07562.x · Cited by 374
Goodson, N. J., Wiles, N. J., Lunt, M., Barrett, E. M., Silman, A. J., & Symmons, D. P. M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10419 · Cited by 366
Methotrexate and histologic hepatic abnormalities: A meta-analysis
Whiting-O'Keefe, Q. E., Fye, K. H., & Sack, K. D. (1991) · The American Journal of Medicine · doi:10.1016/s0002-9343(05)80060-9 · Cited by 358
Krueger, G. G., Papp, K. A., Stough, D. B., Loven, K. H., Gulliver, W. P., & Ellis, C. N. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.127247 · Cited by 338
González-Gay, M. Á., Matias, J. M. D., González‐Juanatey, C., Garcı́a-Porrúa, C., Sanchez-Andrade, A., Martin, J. J., & Llorca, J. (2006) · PubMed · Cited by 313
Escalante, A., Haas, R. W., & del Rincón, I. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.14.1624 · Cited by 290
Dominguez, H., Storgaard, H., Rask-Madsen, C., Steffen Hermann, T., Ihlemann, N., Baunbjerg Nielsen, D., Spohr, C., Kober, L., Vaag, A., & Torp-Pedersen, C. (2005) · Journal of Vascular Research · doi:10.1159/000088261 · Cited by 286
Grisar, J., Aletaha, D., Steiner, C. W., Kapral, T., Steiner, S., Seidinger, D., Weigel, G., Schwarzinger, I., Wolozcszuk, W., Steiner, G., et al. (2005) · Circulation · doi:10.1161/01.cir.0000151875.21836.ae · Cited by 280
Effects of Etanercept in Patients With the Metabolic Syndrome
Bernstein, L. E., Berry, J., Kim, S., Canavan, B., & Grinspoon, S. K. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.8.902 · Cited by 257
Popa, C., Netea, M. G., Radstake, T., Van der Meer, J. W. M., Stalenhoef, A. F. H., van Riel, P. L. C. M., & Barerra, P. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.023119 · Cited by 224
Rocha-Pereira, P., Santos-Silva, A., Rebelo, I., Figueiredo, A., Quintanilha, A., & Teixeira, F. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00358-2 · Cited by 222
Psoriasis and occlusive vascular disease
MCDONALD, C. J., & CALABRESI, P. (1978) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1978.tb02012.x · Cited by 204
Excess Mortality Related to Alcohol and Smoking Among Hospital-Treated Patients With Psoriasis
Poikolainen, K., Karvonen, J., & Pukkala, E. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.12.1490 · Cited by 200
Kural, B. V., Örem, A., Çimşit, G., Yandı, Y. E., & Calapoğlu, M. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00373-x · Cited by 177
Role of non‐alcoholic steatohepatitis in methotrexate‐induced liver injury
Langman, G., Hall, P. D. L. M., & Todd, G. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02644.x · Cited by 173
BONIFATI, C., CARDUCCI, M., FEI, P. C., TRENTO, E., SACERDOTI, G., FAZIO, M., & AMEGLIO, F. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb02687.x · Cited by 171
Obesity as the core of the metabolic syndrome and the management of coronary heart disease
Shirai, K. (2004) · Current Medical Research and Opinion · doi:10.1185/030079903125003008 · Cited by 157
Methotrexate and histologic hepatic abnormalities: A meta-analysis
Whiting-O'Keefe, Q. E., Fye, K. H., & Sack, K. D. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90667-m · Cited by 151
Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis.
Vis, M., Nurmohamed, M. T., Wolbink, G., Voskuyl, A. E., Koning, M. H. M. T. D., van de Stadt, R. J., Twisk, J. W. R., Dijkmans, B. A. C., & Lems, W. F. (2005) · PubMed · Cited by 126
González‐Juanatey, C., Llorca, J., Sanchez-Andrade, A., Garcı́a-Porrúa, C., Martin, J. J., & González-Gay, M. Á. (2006) · PubMed · Cited by 105
Rantapää‐Dahlqvist, S., Engstrand, S., Berglin, E. H., & Johnson, O. (2006) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740500474578 · Cited by 90
Toll‐Like Receptor Expression and Response to Specific Stimulation in Adipocytes and Preadipocytes
Pietsch, J., Batra, A., STROH, T., Fedke, I., Glauben, R., Okur, B., Zeitz, M., & Siegmund, B. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.021 · Cited by 54
Lonardo, A., Loria, P., & Carulli, N. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80144-4 · Cited by 33
Nonalcoholic steatohepatitis associated with psoriasis vulgaris
Matsumoto, T., Suzuki, N., Watanabe, H., Irie, M., Iwata, K., Anan, A., Nakane, H., Yoshikane, M., Nishizawa, S., Sohda, T., et al. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-004-1451-5 · Cited by 17
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Gottlieb, A., Feldman, S. R., Van Voorhees, A. S., Leonardi, C. L., Gordon, K. B., Lebwohl, M., Koo, J. Y. M., Elmets, C. A., Korman, N. J., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.039 · Cited by 1,222
Self-citationGuidelines of care for the management of psoriasis and psoriatic arthritis
Gottlieb, A., Korman, N. J., Gordon, K. B., Feldman, S. R., Lebwohl, M., Koo, J. Y. M., Van Voorhees, A. S., Elmets, C. A., Leonardi, C. L., Beutner, K. R., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.040 · Cited by 769
Self-citationEpidemiology and comorbidity of psoriasis in children
Augustin, M., Glaeske, G., Radtke, M. A., Christophers, E., Reich, K., & Schäfer, I. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09593.x · Cited by 494
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A., Koo, J. Y. M., Lebwohl, M., Leonardi, C. L., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.055 · Cited by 460
Self-citationObesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes
Singh, S., Dulai, P. S., Zarrinpar, A., Ramamoorthy, S., & Sandborn, W. J. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.181 · Cited by 452
Metadata
- Authors
- Sterry, W., Strober, B. E., Menter, A., & on behalf of the International Psoriasis Council
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10
- Volume
- 157
- Issue
- 4
- Pages
- 649-655
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2088922400
- Cited by
- 310
- References
- 58
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.